Per J. Hellsund
Founder at Cybrexa, Inc.
Profile
Per J.
Hellsund is the founder who has founded two companies.
In 2010, he founded Cyvek, Inc. where he held the title of President, Chief Executive Officer & Director.
In 2016, he founded Cybrexa, Inc. where he currently holds the title of President, Chief Executive Officer & Director.
Mr. Hellsund's former jobs include Vice President-Operations & Engineering Director at inc.Jet Holding, Inc. and President at inc.jet, Inc. Mr. Hellsund's education history includes undergraduate and graduate degrees from Rensselaer Polytechnic Institute.
Per J. Hellsund active positions
| Companies | Position | Start |
|---|---|---|
Cybrexa, Inc.
 Cybrexa, Inc. BiotechnologyHealth Technology Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT. | Founder | 31/12/2015 |
Former positions of Per J. Hellsund
| Companies | Position | End |
|---|---|---|
inc.jet, Inc.
 inc.jet, Inc. Commercial Printing/FormsCommercial Services inc.jet, Inc. supplies rugged and effective printing solutions. It develops variable data printing equipment and solutions for the mail, graphics and packaging markets. The company was founded in 1998 and is headquartered in Norwich, CT. | President | - |
| GUNTHER INTL | Chief Operating Officer | - |
CyVek, Inc.
 CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | Founder | - |
Training of Per J. Hellsund
| Rensselaer Polytechnic Institute | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GUNTHER INTL | Electronic Technology |
| Private companies | 3 |
|---|---|
CyVek, Inc.
CyVek, Inc. BiotechnologyHealth Technology CyVek, Inc. engages in the development of a novel, platform technology for measuring analytes in biological samples. It is a biotechnology company dedicated to the advancement of healthcare by empowering researchers and clinicians with a disruptive technology for performing multi-analyte immunoassays. The firm is a versatile platform that can be quickly and easily configured for diverse applications such as rapid diagnostic tests, multi-sample multi-analyte tests, or routine ELISA-like tests, for use in both research and clinical settings. The company offers an breadth of applications, from life science research to drug discovery, personalized medicine, diagnostics, and point-of-care testing. CyVek was founded by Per J. Hellsund, Rajiv Pandey and Marty Andrew Putnam in 2010 and is headquartered in Wallingford, CT. | Health Technology |
inc.jet, Inc.
inc.jet, Inc. Commercial Printing/FormsCommercial Services inc.jet, Inc. supplies rugged and effective printing solutions. It develops variable data printing equipment and solutions for the mail, graphics and packaging markets. The company was founded in 1998 and is headquartered in Norwich, CT. | Commercial Services |
Cybrexa, Inc.
Cybrexa, Inc. BiotechnologyHealth Technology Cybrexa, Inc. develops molecule DNA repair inhibitors that directly target the tumor microenvironment. It develops and commercializes technologies that enables to improve cancer therapeutics. The company was founded by Per J. Hellsund, F. Kevin Didden, Ranjit S. Bindra, and Peter Glazer in 2016 and is headquartered in New Haven, CT. | Health Technology |
- Stock Market
- Insiders
- Per J. Hellsund
